Healthcare Services Group, Inc. (HCSG)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-09-29. ClinicalTrials.gov
Dilution Risk
LOW DILUTION RISKDilution score: 22/100 (LOW), cash runway not available
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 4.48% of float, squeeze risk: MODERATE
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Are Investors Undervaluing Healthcare Services Group (HCSG) Right Now?
- New Strong Buy Stocks for September 28th
- Are Business Services Stocks Lagging Healthcare Services Group (HCSG) This Year?
- Healthcare Services Group (HCSG) Stock Looks Below Fair Value On Cash Flow
- Should Value Investors Buy Healthcare Services Group (HCSG) Stock?
- New Strong Buy Stocks for September 11th
- Healthcare Services (HCSG) Upgraded to Strong Buy: Here's What You Should Know
- Is Healthcare Services Group (HCSG) Stock Outpacing Its Business Services Peers This Year?
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Healthcare Services Group, Inc..
Full HCSG Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.